The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial.

ABSTRACT:

Background

Eighty per cent of UK women have at least one baby, making pregnancy an opportunity to help women stop smoking before their health is irreparably compromised. Smoking cessation during pregnancy helps protect infants from miscarriage, still birth, low birth weight, asthma, attention deficit disorder and adult cardiovascular disease. UK national guidelines highlight lack of evidence for effectiveness of financial incentives to help pregnant smokers quit. This includes a research recommendation: within a UK context, are incentives an acceptable, effective and cost-effective way to help pregnant women who smoke to quit?

Methods

The Cessation in Pregnancy Incentives Trial (CPIT) III is a pragmatic, 42-month, multi-centre, parallel-group, individually randomised control

SUBMITTER: Sinclair L 

PROVIDER: S-EPMC7023794 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature